Contact Michael

Speaking Engagements

  

Instilling Robust QbD, Optimized Process Development & Control Strategy for Next Gen Oligos & Peptides to Ensure Scalability, Regulatory Compliance & Affordability The inaugural Oligos & Peptides Formulation & Process Development Summit is the industry’s first forum bringing together experts addressing challenges and seeking solutions to expedite d

30 August-01 September 2022
  

Greetings! Welcome to the 2nd Annual Oligonucleotides CMC & Analytical Development Summit, focused on accelerating scalability and regulatory approval through tightened QC of oligos for cost-efficient GMP manufacturing. With the oligonucleotides market projected to reach $2 billion by 2027 and over 250 clinical phase drug developments, we aim to ex

29-31 August 2023